Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06342284 · ClinicalTrials.gov registry record

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

A clinical trial of Thoracic Cancer, sponsored by The New York Proton Center.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT06342284 is a study of Thoracic Cancer that is actively recruiting participants, run by The New York Proton Center. The registered enrollment target is 40 participants, below the 346-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06342284, a study of Thoracic Cancer, is actively recruiting participants, sponsored by The New York Proton Center.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.

Conditions Studied

Interventions

  • RADIATION Proton Beam Radiation with or without concurrent chemotherapy

Study Locations (1)

New York

  • New York Proton Center - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-03-22
Est. Completion 2031-03-21

Sponsor

The New York Proton Center

3 total trials

What the Registry Record Tells You About NCT06342284

The ClinicalTrials.gov registry entry for NCT06342284 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 346-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (88% lower). The listed sponsor is The New York Proton Center, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thoracic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Proton Beam Radiation with or without concurrent chemotherapy is the first listed.

NCT06342284 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06342284 about?

NCT06342284 is a clinical study titled "Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer". This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of stu...

What is the current status of trial NCT06342284?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-03-22. Estimated completion is 2031-03-21.

What conditions does trial NCT06342284 study?

This clinical trial studies the following conditions: Thoracic Cancer.

What interventions are being tested in trial NCT06342284?

The interventions under investigation include: Proton Beam Radiation with or without concurrent chemotherapy (RADIATION).

Who is sponsoring clinical trial NCT06342284?

This trial is sponsored by The New York Proton Center, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06342284 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thoracic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.